Skip to main content
No. of Recommendations: 0
Milestone payments do not interest me. They never move the stock. Royalties on profits up to 20% do not interest me. If it is on revenue, let me know. It is most likely on profits. And "up to" means not likely, and most likely in low single digits. None of this moves the needle.

If you want Incyte like performance and valuation or NKTR, you have to take the risk and bring drugs to market that can fail but if they succeed it is a home run.

IONS has 0 home run opportunities at the moment. Instead of bringing every drug under the sun to market, IONS has to settle on 2 or 3 in its pipeline, that are worth the risk, and take the risk.

Tinker
Print the post  

Announcements

What was Your Dumbest Investment?
Share it with us -- and learn from others' stories of flubs.
When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.